Granahan Investment Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-113,322
| Closed | -$986K | – | 188 |
|
|
2022
Q1 | $986K | Sell |
113,322
-265,610
| -70% | -$2.31M | 0.02% | 174 |
|
|
2021
Q4 | $6.07M | Sell |
378,932
-176,682
| -32% | -$2.83M | 0.12% | 142 |
|
|
2021
Q3 | $10.2M | Buy |
555,614
+222,975
| +67% | +$4.11M | 0.19% | 112 |
|
|
2021
Q2 | $4.64M | Sell |
332,639
-9,474
| -3% | -$132K | 0.09% | 157 |
|
|
2021
Q1 | $5.04M | Sell |
342,113
-78,207
| -19% | -$1.15M | 0.11% | 141 |
|
|
2020
Q4 | $8.15M | Buy |
420,320
+46,242
| +12% | +$897K | 0.18% | 103 |
|
|
2020
Q3 | $4.18M | Buy |
374,078
+207,472
| +125% | +$2.32M | 0.14% | 117 |
|
|
2020
Q2 | $2.25M | Sell |
166,606
-4,828
| -3% | -$65.3K | 0.08% | 150 |
|
|
2020
Q1 | $1.39M | Buy |
171,434
+22,567
| +15% | +$182K | 0.07% | 154 |
|
|
2019
Q4 | $1.43M | Buy |
148,867
+1,324
| +0.9% | +$12.7K | 0.07% | 149 |
|
|
2019
Q3 | $1.56M | Buy |
147,543
+9,248
| +7% | +$98K | 0.09% | 147 |
|
|
2019
Q2 | $1.59M | Sell |
138,295
-2,231
| -2% | -$25.7K | 0.08% | 154 |
|
|
2019
Q1 | $1.8M | Sell |
140,526
-13,780
| -9% | -$177K | 0.1% | 156 |
|
|
2018
Q4 | $949K | Sell |
154,306
-2,752
| -2% | -$16.9K | 0.07% | 166 |
|
|
2018
Q3 | $1.65M | Buy |
157,058
+5,910
| +4% | +$62.1K | 0.09% | 167 |
|
|
2018
Q2 | $2.22M | Buy |
+151,148
| New | +$2.22M | 0.13% | 157 |
|